HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shengliang Zhang Selected Research

1- (4- methylpiperazin- 1- yl)- 3- (5- nitrofuran- 2- yl)prop- 2- en- 1- one

1/2022Small-Molecule NSC59984 Induces Mutant p53 Degradation through a ROS-ERK2-MDM2 Axis in Cancer Cells.
9/2015Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shengliang Zhang Research Topics

Disease

18Neoplasms (Cancer)
01/2022 - 12/2012
5Colorectal Neoplasms (Colorectal Cancer)
09/2021 - 09/2015
3Infections
02/2022 - 09/2020
2Colonic Neoplasms (Colon Cancer)
10/2021 - 02/2014
2Carcinogenesis
01/2021 - 09/2015
2Disease Progression
11/2020 - 09/2020
2COVID-19
11/2020 - 09/2020
2Lung Neoplasms (Lung Cancer)
11/2020 - 09/2020
1Bacterial Infections (Bacterial Infection)
02/2022
1Carcinoma (Carcinomatosis)
10/2021
1Peripheral Nervous System Diseases (PNS Diseases)
09/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2021
1Conversion Disorder (Astasia Abasia)
12/2019
1Neoplasm Metastasis (Metastasis)
09/2017
1Hypoxia (Hypoxemia)
01/2014
1Squamous Cell Carcinoma of Head and Neck
03/2006

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
02/2022 - 12/2012
5Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2012
3Irinotecan (Camptosar)FDA LinkGeneric
09/2021 - 09/2015
3CytokinesIBA
09/2021 - 09/2020
21- (4- methylpiperazin- 1- yl)- 3- (5- nitrofuran- 2- yl)prop- 2- en- 1- oneIBA
01/2022 - 09/2015
2Biological ProductsIBA
01/2022 - 09/2017
2Fluorouracil (Carac)FDA LinkGeneric
09/2021 - 09/2017
2Antiviral Agents (Antivirals)IBA
11/2020 - 09/2020
2Peptide Hydrolases (Proteases)FDA Link
11/2020 - 09/2020
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2020 - 09/2020
2Interleukin-6 (Interleukin 6)IBA
11/2020 - 09/2020
2CB002IBA
01/2018 - 09/2017
2ProdigiosinIBA
01/2016 - 02/2014
1Anti-Bacterial Agents (Antibiotics)IBA
02/2022
1Anti-Infective Agents (Microbicides)IBA
02/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022
1Immune Checkpoint InhibitorsIBA
10/2021
1pembrolizumabIBA
10/2021
1Histones (Histone)IBA
09/2021
1Ferritins (Ferritin)IBA
09/2021
1Cisplatin (Platino)FDA LinkGeneric
09/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
09/2021
1Interleukin-8 (Interleukin 8)IBA
09/2021
1ONC212IBA
01/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2020
1Circular RNAIBA
09/2020
1Small Interfering RNA (siRNA)IBA
01/2020
1SolutionsIBA
12/2019
1polysulfideIBA
12/2019
1Apoptosis Regulatory ProteinsIBA
01/2018
1matrigelIBA
09/2017
1Oxygen (Dioxygen)IBA
07/2017
1LuciferasesIBA
01/2016
1Transcription Factors (Transcription Factor)IBA
01/2014
1Caspase 8 (Caspase-8)IBA
03/2006

Therapy/Procedure

13Therapeutics
02/2022 - 12/2012
2Immunotherapy
01/2022 - 10/2021
1Drug Therapy (Chemotherapy)
05/2016
1Radiotherapy
09/2015